| EQIX |
Report |
Revenue |
IN-LINE |
pred ~$2.598B vs. cons $2.591B |
MEDIUM |
| EQIX |
Report |
Diluted AFFO/share |
IN-LINE |
pred ~$11.44 vs. cons $11.364 |
MEDIUM |
| EQIX |
Report |
Annualized gross bookings |
BEAT |
pred ~$420M vs. cons $404M |
MEDIUM |
| EQIX |
Guide |
Q3 revenue (Q3'26) |
UNCHANGED |
guide ~$2.57B-$2.61B vs. cons $2.577B |
MEDIUM |
| EQIX |
Guide |
FY2026 revenue |
UNCHANGED |
guide ~$10.17B-$10.27B vs. cons $10.245B |
MEDIUM |
| EQIX |
Guide |
FY2026 diluted AFFO/share |
UNCHANGED |
guide ~$42.55-$43.35 vs. cons $43.14 |
MEDIUM |
| EQIX |
Guide |
Demand / pricing / capacity commentary (FY2026) |
BETTER |
reaffirm strong AI, interconnection, power and capacity outlook |
MEDIUM |
| EQIX |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.0% |
— |
MEDIUM |
| EQIX |
Return |
5-day cumulative residual |
-1.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — modest estimate/multiple compression |
MEDIUM |